Retrospective Study Collecting Neurological Follow-up of Hereditary Transthyretin Amyloidosis (ATTRv) Patients Included in B3461028 and B3461045.

Clinical trial NCT05560555 · COMPLETED

Trial details

NCT number: NCT05560555
Sponsor: Pfizer
Status: COMPLETED
Study type: OBSERVATIONAL

Hereditary Transthyretin Amyloidosis (ATTRv)Polyneuropathy

Start date: 2022-10-24
Primary completion: 2022-11-15
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.